Trial Profile
Value of Mifepristone in Eliminating the Need for a Second Set of Osmotic Dilators Prior to Dilation and Evacuation Between 19-24 Weeks: A Randomized Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2024
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary) ; Digoxin; Misoprostol
- Indications Abortion; Induced abortion
- Focus Therapeutic Use
- 04 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Jun 2012 New trial record